$12.7B
$1.5 Billion
0.06% of portfolio
7,558
Q2 2025
Added 53.34%
-
$1.45 Billion
0.05% of portfolio
-
Q2 2025
New
$28.6B
$1.21 Billion
0.05% of portfolio
19,181
Q2 2025
Added 31.48%
$10.6B
$1.28 Billion
0.05% of portfolio
5,286
Q2 2025
Added 343.83%
$16.3B
$1.24 Billion
0.05% of portfolio
35,973
Q2 2025
Reduced 38.35%
-
$1.23 Billion
0.05% of portfolio
-
Q2 2025
New
$188B
$1.28 Billion
0.05% of portfolio
3,653
Q2 2025
Reduced 59.43%
$6.7B
$1.33 Billion
0.05% of portfolio
15,454
Q2 2025
Added 148.5%
$13B
$1.28 Billion
0.05% of portfolio
32,041
Q2 2025
Reduced 67.86%
$10.4B
$1.39 Billion
0.05% of portfolio
15,514
Q2 2025
Reduced 17.69%
$11.2B
$1.25 Billion
0.05% of portfolio
13,895
Q2 2025
New
$33.7B
$1.2 Billion
0.05% of portfolio
76,500
Q2 2025
New
$14.4B
$1.22 Billion
0.05% of portfolio
11,143
Q2 2025
New
$5.7B
$1.03 Billion
0.04% of portfolio
12,997
Q2 2025
New
$16B
$950 Million
0.04% of portfolio
5,573
Q2 2025
Added 1,763.88%
$6.86B
$947 Million
0.04% of portfolio
27,358
Q2 2025
Added 1,155.53%
$76.8B
$1.07 Billion
0.04% of portfolio
1,345
Q2 2025
New
-
$1.1 Billion
0.04% of portfolio
-
Q2 2025
New
$14.5B
$1.12 Billion
0.04% of portfolio
3,292
Q2 2025
New
$15.2B
$1.05 Billion
0.04% of portfolio
12,971
Q2 2025
Added 134.01%
$5.47B
$994 Million
0.04% of portfolio
21,112
Q2 2025
Added 29.56%
$4.62B
$990 Million
0.04% of portfolio
10,584
Q2 2025
Reduced 15.27%
$11.9B
$1.18 Billion
0.04% of portfolio
7,153
Q2 2025
New
$27.8B
$1.09 Billion
0.04% of portfolio
12,441
Q2 2025
Reduced 76.58%
$145B
$963 Million
0.04% of portfolio
4,135
Q2 2025
Reduced 89.87%
$4.38B
$1.12 Billion
0.04% of portfolio
19,346
Q2 2025
New
$16.1B
$1.01 Billion
0.04% of portfolio
3,284
Q2 2025
New
$5.87B
$1.16 Billion
0.04% of portfolio
9,360
Q2 2025
New
$4.85B
$937 Million
0.04% of portfolio
11,782
Q2 2025
New
$59.2B
$1 Billion
0.04% of portfolio
23,307
Q2 2025
Reduced 86.98%
$7.25B
$959 Million
0.04% of portfolio
21,681
Q2 2025
Reduced 79.29%
-
$951 Million
0.04% of portfolio
-
Q2 2025
New
$7.65B
$867 Million
0.03% of portfolio
11,616
Q2 2025
New
$7.41B
$774 Million
0.03% of portfolio
16,090
Q2 2025
Added 646.29%
$7.08B
$718 Million
0.03% of portfolio
4,987
Q2 2025
New
$8.29B
$751 Million
0.03% of portfolio
26,458
Q2 2025
New
$2.7B
$817 Million
0.03% of portfolio
51,116
Q2 2025
Added 63,006.17%
$6.7B
$876 Million
0.03% of portfolio
16,741
Q2 2025
Added 119.24%
$9.63B
$703 Million
0.03% of portfolio
3,024
Q2 2025
New
$26.9B
$717 Million
0.03% of portfolio
5,542
Q2 2025
New
$5.48B
$783 Million
0.03% of portfolio
62,982
Q2 2025
Added 818.64%
Ascentage Pharma Group Intl
-
$823 Million
0.03% of portfolio
-
Q2 2025
Reduced 17.77%
$9.19B
$760 Million
0.03% of portfolio
4,681
Q2 2025
Added 27.83%
$42.9B
$806 Million
0.03% of portfolio
7,576
Q2 2025
Reduced 85.81%
$16.6B
$886 Million
0.03% of portfolio
12,808
Q2 2025
New
$7.46B
$911 Million
0.03% of portfolio
6,521
Q2 2025
Added 24.64%
$125B
$704 Million
0.03% of portfolio
8,072
Q2 2025
Reduced 94.64%
$6.05B
$804 Million
0.03% of portfolio
37,683
Q2 2025
New
$30.4B
$905 Million
0.03% of portfolio
428,777
Q2 2025
New
$5.66B
$923 Million
0.03% of portfolio
16,964
Q2 2025
Added 244.1%